Bioinformatics-based identification of capsaicin target genes associated with trastuzumab resistance in HER2-positive breast cancer: in silico and qRT-PCR validation studies.

Published 10/01/2026

Research record: Bioinformatics-based identification of capsaicin target genes associated with trastuzumab resistance in HER2-positive breast cancer: in silico and qRT-PCR validation studies.

Published in In Silico Pharmacol; first publication date 2026-10-01. PMID 42827612.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-01

Updated

2026-10-19

Disclaimer

professional use

References